alexa
Reach Us +1(850)754-6199
Editor - Jie Wang | Ohio State University | 1428
ISSN: 2155-952X

Journal of Biotechnology & Biomaterials
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Jie Wang

Jie Wang
Jie Wang
Senior Research Scientist
Principal Investigator
Project Leader Optimum Therapeutics
Ohio State University
USA

Biography

Jie Wang is a Senior Research Scientist Principal Investigator and Project Leader of Optimum Therapeutics LLC The Ohio State University Science Tech Village Dr Wang earned his PhD in Pharmaceutics from the Ohio State University 2005 MS in Pharmaceutical Sciences from Peking University 2000 and BS in Pharmacy from Beijing Medical University 1997 He is a member of American Association for Cancer Research AACR and American Association for Pharmaceutical Scientists AAPS He has teaching experiences in the field of pharmaceutics and pharmacokinetics He has been serving as reviewer for topranked scientific journals in the area of pharmaceutical sciences experimental pharmacology medicinal chemistry and nanotechnology

Research Interest

Nanomedicine formulation design for targeted drug delivery and development of non-viral vectors for gene (including oligonucleotides) delivery
Pharmacokinetics and pharmacodynamics of drugs in systemic and regional cancer chemo-gene therapy

Certificate

Certificate
Top